GFC Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	6,568	7,470	1,538	1,186	141.89	977.2
Short-Term Investments	-	-	-	24	493.54	528.86
Trading Asset Securities	282.29	297.7	-	-	-	-
Cash & Short-Term Investments	6,851	7,768	1,538	1,210	635.43	1,506
Cash Growth	-45.93%	405.09%	27.10%	90.42%	-57.81%	21.37%
Accounts Receivable	2,441	2,171	1,764	1,714	1,831	1,783
Other Receivables	1.3	3.95	1.39	2.51	7.23	240.38
Receivables	2,442	2,175	1,768	1,717	1,839	2,023
Inventory	1,284	575.82	517.94	632.12	671	481.4
Prepaid Expenses	31.92	88.54	5.35	72.38	245.77	37.73
Other Current Assets	520.18	706.79	118.38	67.84	72.01	88.64
Total Current Assets	11,129	11,314	3,947	3,699	3,463	4,137
Property, Plant & Equipment	22,750	19,499	14,501	12,797	16,057	14,698
Long-Term Investments	392.31	177.95	677.38	824.84	624.67	425.48
Other Intangible Assets	2,378	1,785	462.7	193.63	193.34	252
Long-Term Accounts Receivable	-0	-0	-	-	-	-
Long-Term Deferred Tax Assets	684.98	942.65	222.57	-	-	-
Other Long-Term Assets	104.5	115.11	236.88	508.45	629.85	628.57
Total Assets	37,438	33,833	20,055	18,023	20,967	20,141

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Accounts Payable	372.66	250.36	248.93	303.07	430.56	440.44
Accrued Expenses	439.01	259.11	190.89	356.64	336.87	203.6
Short-Term Debt	-	-	5,000	5,084	1,580	500
Current Portion of Long-Term Debt	-	-	-	320.8	5,336	336.12
Current Portion of Leases	259.59	266.78	427.99	-	-	-
Current Income Taxes Payable	-	-	-	-	-	15.94
Current Unearned Revenue	-	-	-	14.14	14.14	21.55
Other Current Liabilities	1,192	1,245	999.48	919.21	2,436	893.84
Total Current Liabilities	2,263	2,021	6,867	6,998	10,133	2,411
Long-Term Debt	9,184	6,984	1,365	2,021	3,384	7,620
Long-Term Leases	273.39	271.68	229.09	-	-	-
Pension & Post-Retirement Benefits	494.4	449.76	407.87	698.62	562.32	187.67
Other Long-Term Liabilities	315.48	308.42	285.87	70	50	20
Total Liabilities	12,530	10,035	9,155	9,788	14,130	10,239

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Common Stock	2,663	2,627	2,201	518.26	518.26	518.26
Additional Paid-In Capital	22,953	29,845	18,230	8,864	8,864	8,864
Retained Earnings	884.6	-7,441	-7,979	418.77	-1,128	1,804
Treasury Stock	-200	-200	-200	-200	-200	-
Comprehensive Income & Other	-1,393	-1,031	-1,352	-1,546	-1,397	-1,465
Total Common Equity	24,908	23,799	10,900	8,055	6,657	9,721
Shareholders' Equity	24,908	23,799	10,900	8,235	6,838	9,902
Total Liabilities & Equity	37,438	33,833	20,055	18,023	20,967	20,141

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Total Debt	9,717	7,522	7,022	7,426	10,300	8,456
Net Cash (Debt)	-2,866	245.42	-5,484	-6,216	-9,665	-6,950
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-544.79	50.95	-1726.30	-5996.61	-9325.18	-6707.09
Filing Date Shares Outstanding	5.28	5.24	3.49	1.04	1.04	1.04
Total Common Shares Outstanding	5.28	5.24	3.49	1.04	1.04	1.04
Working Capital	8,866	9,293	-2,920	-3,299	-6,670	1,725
Book Value Per Share	4716.06	4541.01	3122.48	7770.77	6423.20	9381.36
Tangible Book Value	22,530	22,014	10,437	7,861	6,464	9,469
Tangible Book Value Per Share	4265.85	4200.50	2989.93	7583.97	6236.66	9138.18
Land	5,546	5,092	4,065	3,813	4,770	4,770
Buildings	11,866	10,405	6,731	6,319	8,499	6,137
Machinery	9,500	8,842	7,535	5,455	4,951	3,441
Construction In Progress	1,393	288.63	130.87	18.93	44.61	2,534